講演情報
[IL3]Integrating Human Genetics and iPSC Modeling Reveals Cholesterol Biosynthesis as a Therapeutic Target in ALS
岡野 栄之 (慶應義塾大学再生医療リサーチセンター)
He received his M.D. from Keio University in 1983 and his Ph.D. in 1988 for studieson myelin-related genes using myelin-deficient mutant mice. After postdoctoral trainingwith Dr. Craig Montell at Johns Hopkins School of Medicine, he became a full professorat the University of Tsukuba in 1994 and Osaka University in 1997.
He returned to Keio University School of Medicine in 2001 as Professor and Chair ofPhysiology and served as Dean from 2015 to 2017. Since 2024, he has been Directorand Distinguished Professor of the Keio University Regenerative Medicine ResearchCenter.
His work spans regenerative medicine, neural stem and iPS cells, spinal cord injury,and RNA biology. He served as President of the ISSCR from 2025 to 2026 and has beena Visiting Professor at MIT since 2022.
He returned to Keio University School of Medicine in 2001 as Professor and Chair ofPhysiology and served as Dean from 2015 to 2017. Since 2024, he has been Directorand Distinguished Professor of the Keio University Regenerative Medicine ResearchCenter.
His work spans regenerative medicine, neural stem and iPS cells, spinal cord injury,and RNA biology. He served as President of the ISSCR from 2025 to 2026 and has beena Visiting Professor at MIT since 2022.
閲覧にはパスワードが必要です
ログイン
または